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Recent studies have indicated the significance of Th9 
cells in a variety of inflammatory and allergy-related 
diseases (see Kaplan et al. (1)). Th9 cells are a distinct 
subset of CD4+ T cells present in the skin, which secrete 
interleukin (IL)-9 (2–4). IL-9 is transiently expressed 
by skin-tropic and skin-resident Th9 cells to regulate 
the production of inflammatory cytokines (5). IL-9, like 
IL-4, is associated with predominantly type 2 immune 
responses, and aberrant IL-9 expression or signalling in 
skin is implicated in allergic contact dermatitis (ACD) 
(6), atopic dermatitis (AD) (7–9), and psoriasis (5, 10). 
Targeting of IL-9 or its receptor may therefore be an inte-
resting new therapeutic avenue to be explored. Although 
the IL-9 receptor (IL9R) is expressed by immune cells 
as well as epithelial cells (11), the majority of research 
focuses on the Th9/IL-9 axis in immune cells. Recent in 
vitro studies, however, have shown the regulation of IL9R 
expression in keratinocytes by IL-4 (12) and increased 
IL9R expression in basal keratinocytes of psoriatic le-
sions (10). Furthermore, IL-9 increased IL-8 (CXCL8) 
and vascular endothelial growth factor (VEGF) secretion 
by keratinocytes in vitro (6, 7). The effects of IL-9 on 
human keratinocytes with regard to epidermal prolife-
ration, differentiation and host defence are still poorly 
understood. This study examined the effects of IL-9 on 
epidermal morphology, proliferation, differentiation and 
host defence, and studied cytokine-mediated regulation 
of IL9R expression on keratinocytes, and investigated 
the potential additive or synergistic effects by IL-9 in 
Th2-cytokine mediated epidermal responses. 
MATERIALS AND METHODS
Human epidermal equivalents (HEEs) and monolayer cultures 
generated from adult primary human keratinocytes were exposed 
to human recombinant IL-9 or other pro-inflammatory cytokines, 
as indicated. Epidermal morphology was studied by histology, and 
gene and protein expression was analysed by quantitative PCR 
analysis and immunohistochemistry, respectively. For detailed 
description, see Appendix S11.
RESULTS
First, a dose range of IL-9 was tested on differentiating 
submerged keratinocyte monolayer cultures and no 
effect on cell morphology and viability was observed, 
even at the highest concentration of 500 ng/ml (data not 
shown). For further in depth analysis of keratinocyte 
proliferation and differentiation, HEEs were exposed to 
50 ng/ml human recombinant IL-9, being a biologically 
relevant concentration as shown by the induction of 
CXCL8 expression (Fig. 1, (10)). After 72 h of IL-9 sti-
mulation, HEEs showed normal epidermal morphology 
with a fully stratified epidermis and a well-developed 
stratum corneum (Fig. S1a1). The number of proliferating 
cells, measured with Ki67 staining, and the epidermal 
thickness was similar to that of control HEEs (Figs S1a 
and  S21). Next, we analysed the expression of the major 
epidermal differentiation proteins, keratin 10 (K10), 
involucrin (IVL), filaggrin (FLG) and loricrin (LOR) 
(Fig. S1b1). For all markers, IL-9 did not alter protein 
localization or expression levels, nor did it change the 
expression of epidermal differentiation genes (Fig. S31). 
Also, marker expression for keratinocyte activation or 
host defence, namely keratin 16 (K16) and SKALP 
remained unaffected. Human beta defensin 2 (hBD2) 
is absent in unstimulated HEEs and is also not induced 
by IL-9 (Fig. S1c1). This in contrast to the classical Th2 
cytokines, IL-4 and IL-13, which downregulated FLG, 
LOR and IVL expression (Fig. S4a1) and induced K16 
and SKALP expression (Fig. S4b1). 
The suggested role of IL-9 in atopic diseases, which are 
largely Th2 driven, led us to investigate the interaction 
of IL-9 with IL-4 and/or IL-13. Co-stimulation with IL-9 
did not alter the effect of Th2 cytokines on downregula-
tion of epidermal differentiation proteins (Fig. S5a1) or 
the induction of inflammatory epidermal markers, K16 
and SKALP (Figs S5b and S61).
We hypothesized that the absence of significant ef-
fects by IL-9 in our study could be due to low IL9R 
expression (mean Ct value 34) under the conditions 
described above. IL9R expression appears to be in-
duced in inflammatory processes, and we therefore 
stimulated keratinocyte monolayers and HEEs with 
various cytokine combinations and found interferon 
gamma (IFN-γ) to be the main inducer of IL9R expres-
sion (Fig. 2). We determined the minimal, but effective, 
IFN-γ exposure time and observed significantly induced 
IL9R expression after 6 h of IFN-γ stimulation (Fig. 
S71). Thereafter, HEEs were exposed to IL-9 for 72 h. 
IFN-γ alone induced the mRNA expression of IVL, and 
the chemokines CCL5 and CXLC10, yet no additional 
effect of IL-9 stimulation was observed on these or 
other genes analysed (Fig. S8A1). Similar to previous 
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experiments, IL-9 did not alter epidermal morphology 
or differentiation protein expression (K10, IVL, LOR 
and FLG) even under conditions of high IL9R expression 
due to 6 h IFN-γ pre-stimulation (Fig. S8B1). 
DISCUSSION
This study explored the potential effects of IL-9 on ke-
ratinocytes and investigated its potential role in multiple 
biological processes involved in epidermal homeostasis, 
such as proliferation, differentiation, host defence and 
inflammatory responses. Even after the induction of 
IL9R in keratinocytes we did not detect any effect of 
IL-9 on any of the aforementioned processes, besides 
the induction of CXCL8 mRNA expression, which has 
been reported previously (12). Induced expression of 
this chemokine may potentially aid in the inflammatory 
process mediated by Th9 cells and cytokines. 
Our data indicate that IL9R expression in human 
keratinocytes is constitutively low, but highly inducible 
upon inflammatory conditions, and that this regulation is 
mainly due to IFN-γ. This finding is in line with the upre-
gulated expression of this receptor as found in psoriasis 
and allergic contact dermatitis (2, 3, 5), where IFN-γ 
levels prevail and contribute to disease pathogenesis. In 
contrast, Hong et al. (12) found IL9R to be upregulated 
by IL-4. We did not detect Th2-cytokine mediated induc-
tion of IL9R mRNA expression in HEEs (Fig. 1A) or 
monolayer cultures (data not shown). The differences in 
cell source or post-transcriptional regulation may explain 
this discrepancy, since Hong et al. studied IL9R protein 
expression in foreskin keratinocytes. 
The limitation of the current study is that we exami-
ned a selection of genes. Genome-wide transcriptomic 
analysis may reveal additional IL-9 responsive genes 
in epidermal keratinocytes, other than CXCL8 reported 
here, but this is outside the scope of the current study. 
Based on our data we conclude that IL-9 does not affect 
important keratinocyte functions, such as proliferation 
or transcription of major differentiation-related genes 
involved in skin barrier function. 
The authors declare no conflicts of interest.
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Fig. 1. Interleukin-9 (IL-9) induces epidermal 
CXCL8 expression. CXCL8 mRNA expression of 
human epidermal equivalents stimulated with IL-9 
(50 ng/ml) for 72 h. Bars represent mean ± standard 
deviation (SD), n = 3 keratinocyte donors, *p < 0.05.
Fig. 2. IL-9R expression after pro-inflammatory cytokine stimulation. IL9R mRNA 
expression of submerged keratinocytes stimulated for 48 h with single cytokines or mixes 
thereof: Th1: IL-1a (30 ng/ml), TNF-α (30 ng/ml), IFN-γ (500 U/ml), Th2: IL-4 (50 ng/
ml), IL-13 (50 ng/ml), Th17: IL-17 (30 ng/ml), IL-22 (30 ng/ml). Boxplots represent 
mean ± standard deviation (SD), n = 3 keratinocyte donors, *p < 0.05.
